Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 1839 (118th)

Combating Illicit Xylazine Act

referredUnited States· United States Congress· EN

Introduced

28 March 2023

Last action

7 April 2023 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Panetta, Jimmy [D-CA-19], Rep. Pfluger, August [R-TX-11], Rep. Bilirakis, Gus M. [R-FL-12], Rep. Buck, Ken [R-CO-4], Rep. Pappas, Chris [D-NH-1], Rep. Bacon, Don [R-NE-2], Rep. Lamborn, Doug [R-CO-5], Rep. Vasquez, Gabe [D-NM-2], Rep. Thompson, Mike [D-CA-4], Rep. Houlahan, Chrissy [D-PA-6], Rep. Trone, David J. [D-MD-6], Rep. Kuster, Ann M. [D-NH-2], Rep. Cline, Ben [R-VA-6], Rep. Van Drew, Jefferson [R-NJ-2], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Nunn, Zachary [R-IA-3], Rep. Harder, Josh [D-CA-9], Rep. Trahan, Lori [D-MA-3], Rep. Kean, Thomas H. [R-NJ-7], Rep. Craig, Angie [D-MN-2], Rep. Norcross, Donald [D-NJ-1], Rep. Quigley, Mike [D-IL-5], Rep. Perez, Marie Gluesenkamp [D-WA-3], Rep. Evans, Dwight [D-PA-3], Yadira Caraveo, Rescom. González-Colón, Jenniffer [R-PR-At Large], Rep. Spanberger, Abigail Davis [D-VA-7], Rep. Cohen, Steve [D-TN-9], Rep. Harris, Andy [R-MD-1], Rep. Ross, Deborah K. [D-NC-2], Lori Chavez-DeRemer, Rep. Wenstrup, Brad R. [R-OH-2], Mike Garcia, Rep. Correa, J. Luis [D-CA-46], Rep. Budzinski, Nikki [D-IL-13], Rep. Norman, Ralph [R-SC-5], Rep. Wild, Susan [D-PA-7], Rep. Neguse, Joe [D-CO-2], Rep. Manning, Kathy E. [D-NC-6], Rep. Clarke, Yvette D. [D-NY-9], Rep. Matsui, Doris O. [D-CA-7], Rep. Bean, Aaron [R-FL-4], Rep. Swalwell, Eric [D-CA-15], Rep. Lucas, Frank D. [R-OK-3], Rep. Dean, Madeleine [D-PA-4], Rep. Mann, Tracey [R-KS-1], Rep. Crenshaw, Dan [R-TX-2], Rep. Harshbarger, Diana [R-TN-1]

Subjects

Discovery layer

Source updated

5 December 2025

Summary

Combating Illicit Xylazine Act This bill criminalizes the illicit use of xylazine. (Xylazine, also known as Tranq , is a sedative that is approved for use in animals. The Drug Enforcement Administration (DEA) has reported an increase in the trafficking of fentanyl mixed with xylazine.) Specifically, the bill establishes criminal penalties for manufacturing, distributing, or dispensing, or possessing with intent to manufacture, distribute, or dispense, xylazine for illicit use (i.e., for use in humans) in accordance with the penalties for schedule III substances (up to 10 years imprisonment or, if death or serious bodily injury occurs, up to 15 years imprisonment, as well as criminal fines). In addition, the DEA must coordinate with the Food and Drug Administration to report on the prevalence of the illicit use of xylazine, including associated supply chains. The bill also declares the illicit use of xylazine as an emerging drug threat.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 28 March 2023

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 28 March 2023

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 28 March 2023

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 7 April 2023

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 28 March 2023

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 28 March 2023

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 28 March 2023

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 104 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.